Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells

Journal of Medicinal Chemistry (2020) - Comments
pubmed: 32524814 doi: 10.1021/acs.jmedchem.0c00694 issn: 0022-2623 issn: 1520-4804

Ferdaous Sahli, Manon. Courcelle, Tony Palama, Nadia Djaker, Philippe Savarin, Jolanda Spadavecchia